Why is Shukra Pharma. falling/rising?

As of 12-Aug, Shukra Pharmaceuticals Ltd is experiencing a price increase, currently at 18.68, with a change of 0.32, representing a rise of 1.74%. Today's price summary indicates that the stock has outperformed its sector by 1.36% and has shown a trend reversal after seven consecutive days of decline. The stock's performance over various periods reveals a year-to-date increase of 36.98% and an impressive 154.01% return over the past year, significantly outperforming the BSE500 in each of the last three annual periods. Additionally, the company maintains a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 1.28 times, and has demonstrated healthy long-term growth with an annual operating profit growth rate of 60.53%.
In the broader market context, while Shukra Pharmaceuticals has faced a short-term decline of 6.04% over the past week, this is notably more significant than the benchmark Sensex, which has only decreased by 0.59% during the same period. The stock's recent upward movement, alongside rising investor participation reflected by a 27.08% increase in delivery volume, suggests a potential recovery phase. Despite the recent volatility, the stock's strong historical performance and positive financial indicators contribute to a favorable outlook amidst a challenging market environment.